## **Core Concept**
Recombinant Parathyroid Hormone (PTH) is used for the treatment of osteoporosis and involves the use of genetically engineered PTH. This hormone plays a crucial role in regulating calcium levels in the blood.

## **Why the Correct Answer is Right**
The correct answer, **Teriparatide**, is a recombinant form of PTH(1-34), meaning it is a genetically engineered version of the first 34 amino acids of parathyroid hormone. This fragment is known for its ability to stimulate bone growth and is used in the treatment of osteoporosis. Teriparatide works by stimulating osteoblasts, which are the bone-building cells, thereby increasing bone mineral density.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not correspond to a well-known recombinant PTH.
- **Option B:** This could potentially refer to another form of PTH but is not recognized as a recombinant PTH used clinically.
- **Option D:** This option does not represent a known recombinant form of PTH.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Teriparatide** is the only FDA-approved recombinant PTH for the treatment of osteoporosis. It is administered via daily injections and has been shown to significantly reduce the risk of vertebral and non-vertebral fractures.

## **Correct Answer:** . **Teriparatide**